Leadiant wins suspension of Italian antitrust decision pending appeal
MLex Summary: Leadiant Biosciences has persuaded an Italian court to suspend a landmark antitrust order on high drug prices pending the company's appeal, according to a ruling from last week. The...To view the full article, register now.
Already a subscriber? Click here to view full article